TMS Treatment With The H1 Coil in Youth Age 10-21 Effective In Ameliorating MDD Symptoms

Abstract

Background: Analysis of collected data was performed in order to determine the effectiveness of deep Transcranial Magnetic Stimulation (dTMS) on treating depression symptoms on a sample of youth ages 10-21 years old. Methods: Twelve patients ages 10 to 21 received dTMS treatment for depression. dTMS was delivered heterogeneously with the H1 coil with targeting the LDLPFC with either a high frequency protocol. or Intermittent Theta Burst Stimulation (iTBS). Participants received a range of treatments from 18 to 65, with a mean of 39.33. Phq9 and BDI were collected throughout treatment and either the last measurement or the first BDI/PHq9 taken after the thirtieth treatment were used for analysis. Results: The performance of a paired T-test demonstrated an overall significant reduction in baseline PHQ9 scores after a course of treatment, t(11) = 2.26, P < .05, d = 0.55. Patients age was not correlated with reduction in PHQ9 scores (r = .01, ns.) Conclusion: Results indicate that dTMS reduces depression symptoms in MDD patients ages 10-21 years old. Results suggest that reduction of symptoms is not correlated with age. Conflicts of Interest: None to report Funding: Brainsway/Brooklyn Minds